Income Statement

Currency: EUR

	Mar-2019	Jun-2019	Dec-2019	Jun-2020	Dec-2020	Jun-2021	Dec-2021	Jun-2022	Dec-2022	Jun-2023	Dec-2023	Jun-2024
Revenue
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0
Revenue	60 N/A	62 +3%	50 -19%	44 -12%	43 -3%	43 +0%	45 +4%	49 +11%	53 +8%	58 +9%	59 +2%	61 +3%
Gross Profit
Cost of Revenue	(25)	(27)	(19)	(17)	(18)	(18)	(19)	(21)	(23)	(25)	(24)	(25)
Gross Profit	35 N/A	35 +1%	31 -11%	27 -11%	25 -8%	25 -2%	26 +4%	28 +10%	30 +7%	34 +12%	36 +6%	36 +1%
Operating Income
Operating Expenses	(23)	(24)	(25)	(23)	(19)	(19)	(20)	(22)	(22)	(25)	(27)	(27)
Selling, General & Administrative	(5)	(5)	(5)	(5)	(4)	(4)	(4)	(5)	(5)	(5)	(6)	(6)
Depreciation & Amortization	(2)	(2)	(2)	(2)	(2)	(2)	(3)	(2)	(3)	(3)	(4)	(4)
Other Operating Expenses	(16)	(17)	(18)	(15)	(13)	(13)	(13)	(14)	(14)	(16)	(18)	(17)
Operating Income	11 N/A	11 -8%	6 -43%	5 -19%	6 +29%	6 -12%	6 +8%	7 +10%	8 +23%	9 +6%	8 -2%	9 +4%
Pre-Tax Income
Interest Income Expense	(0)	(0)	(0)	(0)	(1)	(1)	(0)	(0)	(0)	(0)	(0)	(0)
Non-Reccuring Items	(0)	(1)	(1)	(1)	(0)	(0)	(0)	(0)	0	0	(0)	(0)
Total Other Income	0	(0)	0	0	(0)	0	(0)	(0)	(0)	(0)	(0)	(0)
Pre-Tax Income	11 N/A	9 -12%	5 -48%	4 -19%	5 +33%	4 -15%	6 +27%	6 +10%	8 +31%	9 +6%	8 -7%	9 +6%
Net Income
Tax Provision	(4)	(4)	(2)	(1)	(1)	(1)	(2)	(2)	(2)	(3)	(2)	(2)
Income from Continuing Operations	7	5	3	3	4	3	4	4	6	6	6	6
Income to Minority Interest	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)
Net Income (Common)	7 N/A	5 -23%	3 -46%	3 +1%	4 +38%	3 -12%	4 +14%	4 +8%	6 +40%	6 +3%	6 -7%	6 +7%
EPS (Diluted)	0.59 N/A	0.46 -22%	0.25 -46%	0.25 N/A	0.34 +36%	0.3 -12%	0.34 +13%	0.37 +9%	0.52 +41%	0.54 +4%	0.5 -7%	0.53 +6%

Shedir Pharma Srl Unipersonale
MIL:SHE